RTRIX
Price
$7.15
Change
-$0.15 (-2.05%)
Updated
Feb 3 closing price
Net Assets
943.53M
UBVVX
Price
$82.18
Change
-$2.64 (-3.11%)
Updated
Feb 3 closing price
Net Assets
8.97B
Interact to see
Advertisement

RTRIX vs UBVVX

Header iconRTRIX vs UBVVX Comparison
Open Charts RTRIX vs UBVVXBanner chart's image
Royce Small-Cap Total Return Instl
Price$7.15
Change-$0.15 (-2.05%)
VolumeN/A
Net Assets943.53M
Undiscovered Managers Behavioral Val R5
Price$82.18
Change-$2.64 (-3.11%)
VolumeN/A
Net Assets8.97B
RTRIX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
RTRIX vs. UBVVX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RTRIX is a Buy and UBVVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 8.97B vs. RTRIX (944M). UBVVX pays higher dividends than RTRIX: UBVVX (1.73) vs RTRIX (1.27). RTRIX was incepted earlier than UBVVX: RTRIX (23 years) vs UBVVX (9 years). RTRIX (1.12) is less costly to investors than UBVVX (0.94). RTRIX is a more actively managed with annual turnover of: 51.00 vs. UBVVX (35.00). UBVVX has a lower initial minimum investment than RTRIX: UBVVX (0) vs RTRIX (1000000). UBVVX annual gain was more profitable for investors over the last year : -1.54 vs. RTRIX (-3.30). UBVVX return over 5 years is better than : 25.41 vs. RTRIX (-18.58).
RTRIXUBVVXRTRIX / UBVVX
Total Expense Ratio1.020.90113%
Annual Report Gross Expense Ratio1.120.94119%
Fund Existence23 years9 years-
Gain YTD6.0835.130119%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets944M8.97B11%
Annual Yield % from dividends1.271.7373%
Returns for 1 year-3.30-1.54214%
Returns for 3 years4.864.9498%
Returns for 5 years-18.5825.41-73%
Returns for 10 years-21.54N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FDMT9.490.34
+3.72%
4D Molecular Therapeutics
IMUX0.66N/A
+0.28%
Immunic
NHC148.89-0.40
-0.27%
National Healthcare Corp
AMIX0.40-0.01
-1.43%
Autonomix Medical Inc
NVMI445.66-8.49
-1.87%
Nova Ltd